 | • レポートコード：MRC2-11QY11372 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は慢性尋常性乾癬治療薬のグローバル市場について調査・分析したレポートです。種類別（臨床、非臨床、非アクティブ）市場規模、用途別（病院、外来手術センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別慢性尋常性乾癬治療薬の競争状況、市場シェア ・世界の慢性尋常性乾癬治療薬市場：種類別市場規模 2015年-2020年（臨床、非臨床、非アクティブ） ・世界の慢性尋常性乾癬治療薬市場：種類別市場規模予測 2021年-2026年（臨床、非臨床、非アクティブ） ・世界の慢性尋常性乾癬治療薬市場：用途別市場規模 2015年-2020年（病院、外来手術センター、その他） ・世界の慢性尋常性乾癬治療薬市場：用途別市場規模予測 2021年-2026年（病院、外来手術センター、その他） ・北米の慢性尋常性乾癬治療薬市場分析：米国、カナダ ・ヨーロッパの慢性尋常性乾癬治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの慢性尋常性乾癬治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の慢性尋常性乾癬治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの慢性尋常性乾癬治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbvie、Novartis International、Pfizer、Merck、Astelllas Pharma、GlaxoSmithKline ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Psoriasis is an autoimmune disease which is characterized by scaly patches of skin with inflammation and causes excessive production of new skin cells. Presently, there are no long term therapeutics available for the treatment of psoriasis. Chronic Plaque psoriasis is the one of the most common type of psoriasis. This disease condition is associated with several risk factors such as infection, psychological stress and others. Diagnosis of chronic plaque psoriasis is based on clinical appearance, is the case is severe then biopsy is recommended by the healthcare professionals in order to distinguish it from other conditions such as seborrheic dermatitis, ichen simplex chronicus and others.
Increasing uptake of biological drugs is one of the major factor propelling the growth of the global chronic plaque psoriasis therapeutics market. Advances in inflammation and immunology research, introduction of innovative drugs and increased focus on the usage of combination therapies are further accentuating the demand for chronic plaque psoriasis drugs.
Market Analysis and Insights: Global Chronic Plaque Psoriasis Therapeutics Market
The global Chronic Plaque Psoriasis Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Chronic Plaque Psoriasis Therapeutics Scope and Market Size
Chronic Plaque Psoriasis Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Chronic Plaque Psoriasis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbvie
Novartis International
Pfizer
Merck
Astelllas Pharma
GlaxoSmithKline
…
Market segment by Type, the product can be split into
Clinical
Non-Clinical
Inactive
Market segment by Application, split into
Hospitals
Ambulatory Surgical Centers
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Chronic Plaque Psoriasis Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Chronic Plaque Psoriasis Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Clinical
1.4.3 Non-Clinical
1.4.4 Inactive
1.5 Market by Application
1.5.1 Global Chronic Plaque Psoriasis Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Ambulatory Surgical Centers
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Chronic Plaque Psoriasis Therapeutics Market Perspective (2015-2026)
2.2 Global Chronic Plaque Psoriasis Therapeutics Growth Trends by Regions
2.2.1 Chronic Plaque Psoriasis Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Chronic Plaque Psoriasis Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Chronic Plaque Psoriasis Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Chronic Plaque Psoriasis Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Chronic Plaque Psoriasis Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Chronic Plaque Psoriasis Therapeutics Players by Market Size
3.1.1 Global Top Chronic Plaque Psoriasis Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Chronic Plaque Psoriasis Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Chronic Plaque Psoriasis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Chronic Plaque Psoriasis Therapeutics Market Concentration Ratio
3.2.1 Global Chronic Plaque Psoriasis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Chronic Plaque Psoriasis Therapeutics Revenue in 2019
3.3 Chronic Plaque Psoriasis Therapeutics Key Players Head office and Area Served
3.4 Key Players Chronic Plaque Psoriasis Therapeutics Product Solution and Service
3.5 Date of Enter into Chronic Plaque Psoriasis Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Chronic Plaque Psoriasis Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Chronic Plaque Psoriasis Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Chronic Plaque Psoriasis Therapeutics Market Size by Application (2015-2020)
5.2 Global Chronic Plaque Psoriasis Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Chronic Plaque Psoriasis Therapeutics Market Size (2015-2020)
6.2 Chronic Plaque Psoriasis Therapeutics Key Players in North America (2019-2020)
6.3 North America Chronic Plaque Psoriasis Therapeutics Market Size by Type (2015-2020)
6.4 North America Chronic Plaque Psoriasis Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Chronic Plaque Psoriasis Therapeutics Market Size (2015-2020)
7.2 Chronic Plaque Psoriasis Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Chronic Plaque Psoriasis Therapeutics Market Size by Type (2015-2020)
7.4 Europe Chronic Plaque Psoriasis Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Chronic Plaque Psoriasis Therapeutics Market Size (2015-2020)
8.2 Chronic Plaque Psoriasis Therapeutics Key Players in China (2019-2020)
8.3 China Chronic Plaque Psoriasis Therapeutics Market Size by Type (2015-2020)
8.4 China Chronic Plaque Psoriasis Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Chronic Plaque Psoriasis Therapeutics Market Size (2015-2020)
9.2 Chronic Plaque Psoriasis Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Chronic Plaque Psoriasis Therapeutics Market Size by Type (2015-2020)
9.4 Japan Chronic Plaque Psoriasis Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Chronic Plaque Psoriasis Therapeutics Market Size (2015-2020)
10.2 Chronic Plaque Psoriasis Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Chronic Plaque Psoriasis Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Chronic Plaque Psoriasis Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Chronic Plaque Psoriasis Therapeutics Market Size (2015-2020)
11.2 Chronic Plaque Psoriasis Therapeutics Key Players in India (2019-2020)
11.3 India Chronic Plaque Psoriasis Therapeutics Market Size by Type (2015-2020)
11.4 India Chronic Plaque Psoriasis Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Chronic Plaque Psoriasis Therapeutics Market Size (2015-2020)
12.2 Chronic Plaque Psoriasis Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Chronic Plaque Psoriasis Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Chronic Plaque Psoriasis Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbvie
13.1.1 Abbvie Company Details
13.1.2 Abbvie Business Overview
13.1.3 Abbvie Chronic Plaque Psoriasis Therapeutics Introduction
13.1.4 Abbvie Revenue in Chronic Plaque Psoriasis Therapeutics Business (2015-2020))
13.1.5 Abbvie Recent Development
13.2 Novartis International
13.2.1 Novartis International Company Details
13.2.2 Novartis International Business Overview
13.2.3 Novartis International Chronic Plaque Psoriasis Therapeutics Introduction
13.2.4 Novartis International Revenue in Chronic Plaque Psoriasis Therapeutics Business (2015-2020)
13.2.5 Novartis International Recent Development
13.3 Pfizer
13.3.1 Pfizer Company Details
13.3.2 Pfizer Business Overview
13.3.3 Pfizer Chronic Plaque Psoriasis Therapeutics Introduction
13.3.4 Pfizer Revenue in Chronic Plaque Psoriasis Therapeutics Business (2015-2020)
13.3.5 Pfizer Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview
13.4.3 Merck Chronic Plaque Psoriasis Therapeutics Introduction
13.4.4 Merck Revenue in Chronic Plaque Psoriasis Therapeutics Business (2015-2020)
13.4.5 Merck Recent Development
13.5 Astelllas Pharma
13.5.1 Astelllas Pharma Company Details
13.5.2 Astelllas Pharma Business Overview
13.5.3 Astelllas Pharma Chronic Plaque Psoriasis Therapeutics Introduction
13.5.4 Astelllas Pharma Revenue in Chronic Plaque Psoriasis Therapeutics Business (2015-2020)
13.5.5 Astelllas Pharma Recent Development
13.6 GlaxoSmithKline
13.6.1 GlaxoSmithKline Company Details
13.6.2 GlaxoSmithKline Business Overview
13.6.3 GlaxoSmithKline Chronic Plaque Psoriasis Therapeutics Introduction
13.6.4 GlaxoSmithKline Revenue in Chronic Plaque Psoriasis Therapeutics Business (2015-2020)
13.6.5 GlaxoSmithKline Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Chronic Plaque Psoriasis Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Chronic Plaque Psoriasis Therapeutics Revenue
Table 3. Ranking of Global Top Chronic Plaque Psoriasis Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Chronic Plaque Psoriasis Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Clinical
Table 6. Key Players of Non-Clinical
Table 7. Key Players of Inactive
Table 8. Global Chronic Plaque Psoriasis Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Chronic Plaque Psoriasis Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Chronic Plaque Psoriasis Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Chronic Plaque Psoriasis Therapeutics Market Share by Regions (2015-2020)
Table 12. Global Chronic Plaque Psoriasis Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Chronic Plaque Psoriasis Therapeutics Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Chronic Plaque Psoriasis Therapeutics Market Growth Strategy
Table 18. Main Points Interviewed from Key Chronic Plaque Psoriasis Therapeutics Players
Table 19. Global Chronic Plaque Psoriasis Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 20. Global Chronic Plaque Psoriasis Therapeutics Market Share by Players (2015-2020)
Table 21. Global Top Chronic Plaque Psoriasis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Plaque Psoriasis Therapeutics as of 2019)
Table 22. Global Chronic Plaque Psoriasis Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Chronic Plaque Psoriasis Therapeutics Product Solution and Service
Table 25. Date of Enter into Chronic Plaque Psoriasis Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Chronic Plaque Psoriasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 28. Global Chronic Plaque Psoriasis Therapeutics Market Size Share by Type (2015-2020)
Table 29. Global Chronic Plaque Psoriasis Therapeutics Revenue Market Share by Type (2021-2026)
Table 30. Global Chronic Plaque Psoriasis Therapeutics Market Size Share by Application (2015-2020)
Table 31. Global Chronic Plaque Psoriasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 32. Global Chronic Plaque Psoriasis Therapeutics Market Size Share by Application (2021-2026)
Table 33. North America Key Players Chronic Plaque Psoriasis Therapeutics Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Chronic Plaque Psoriasis Therapeutics Market Share (2019-2020)
Table 35. North America Chronic Plaque Psoriasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 36. North America Chronic Plaque Psoriasis Therapeutics Market Share by Type (2015-2020)
Table 37. North America Chronic Plaque Psoriasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 38. North America Chronic Plaque Psoriasis Therapeutics Market Share by Application (2015-2020)
Table 39. Europe Key Players Chronic Plaque Psoriasis Therapeutics Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Chronic Plaque Psoriasis Therapeutics Market Share (2019-2020)
Table 41. Europe Chronic Plaque Psoriasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Chronic Plaque Psoriasis Therapeutics Market Share by Type (2015-2020)
Table 43. Europe Chronic Plaque Psoriasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Chronic Plaque Psoriasis Therapeutics Market Share by Application (2015-2020)
Table 45. China Key Players Chronic Plaque Psoriasis Therapeutics Revenue (2019-2020) (Million US$)
Table 46. China Key Players Chronic Plaque Psoriasis Therapeutics Market Share (2019-2020)
Table 47. China Chronic Plaque Psoriasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 48. China Chronic Plaque Psoriasis Therapeutics Market Share by Type (2015-2020)
Table 49. China Chronic Plaque Psoriasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 50. China Chronic Plaque Psoriasis Therapeutics Market Share by Application (2015-2020)
Table 51. Japan Key Players Chronic Plaque Psoriasis Therapeutics Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Chronic Plaque Psoriasis Therapeutics Market Share (2019-2020)
Table 53. Japan Chronic Plaque Psoriasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Chronic Plaque Psoriasis Therapeutics Market Share by Type (2015-2020)
Table 55. Japan Chronic Plaque Psoriasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Chronic Plaque Psoriasis Therapeutics Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Chronic Plaque Psoriasis Therapeutics Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Chronic Plaque Psoriasis Therapeutics Market Share (2019-2020)
Table 59. Southeast Asia Chronic Plaque Psoriasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Chronic Plaque Psoriasis Therapeutics Market Share by Type (2015-2020)
Table 61. Southeast Asia Chronic Plaque Psoriasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Chronic Plaque Psoriasis Therapeutics Market Share by Application (2015-2020)
Table 63. India Key Players Chronic Plaque Psoriasis Therapeutics Revenue (2019-2020) (Million US$)
Table 64. India Key Players Chronic Plaque Psoriasis Therapeutics Market Share (2019-2020)
Table 65. India Chronic Plaque Psoriasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 66. India Chronic Plaque Psoriasis Therapeutics Market Share by Type (2015-2020)
Table 67. India Chronic Plaque Psoriasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 68. India Chronic Plaque Psoriasis Therapeutics Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Chronic Plaque Psoriasis Therapeutics Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Chronic Plaque Psoriasis Therapeutics Market Share (2019-2020)
Table 71. Central & South America Chronic Plaque Psoriasis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Chronic Plaque Psoriasis Therapeutics Market Share by Type (2015-2020)
Table 73. Central & South America Chronic Plaque Psoriasis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Chronic Plaque Psoriasis Therapeutics Market Share by Application (2015-2020)
Table 75. Abbvie Company Details
Table 76. Abbvie Business Overview
Table 77. Abbvie Product
Table 78. Abbvie Revenue in Chronic Plaque Psoriasis Therapeutics Business (2015-2020) (Million US$)
Table 79. Abbvie Recent Development
Table 80. Novartis International Company Details
Table 81. Novartis International Business Overview
Table 82. Novartis International Product
Table 83. Novartis International Revenue in Chronic Plaque Psoriasis Therapeutics Business (2015-2020) (Million US$)
Table 84. Novartis International Recent Development
Table 85. Pfizer Company Details
Table 86. Pfizer Business Overview
Table 87. Pfizer Product
Table 88. Pfizer Revenue in Chronic Plaque Psoriasis Therapeutics Business (2015-2020) (Million US$)
Table 89. Pfizer Recent Development
Table 90. Merck Company Details
Table 91. Merck Business Overview
Table 92. Merck Product
Table 93. Merck Revenue in Chronic Plaque Psoriasis Therapeutics Business (2015-2020) (Million US$)
Table 94. Merck Recent Development
Table 95. Astelllas Pharma Company Details
Table 96. Astelllas Pharma Business Overview
Table 97. Astelllas Pharma Product
Table 98. Astelllas Pharma Revenue in Chronic Plaque Psoriasis Therapeutics Business (2015-2020) (Million US$)
Table 99. Astelllas Pharma Recent Development
Table 100. GlaxoSmithKline Company Details
Table 101. GlaxoSmithKline Business Overview
Table 102. GlaxoSmithKline Product
Table 103. GlaxoSmithKline Revenue in Chronic Plaque Psoriasis Therapeutics Business (2015-2020) (Million US$)
Table 104. GlaxoSmithKline Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Plaque Psoriasis Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Clinical Features
Figure 3. Non-Clinical Features
Figure 4. Inactive Features
Figure 5. Global Chronic Plaque Psoriasis Therapeutics Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Others Case Studies
Figure 9. Chronic Plaque Psoriasis Therapeutics Report Years Considered
Figure 10. Global Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Chronic Plaque Psoriasis Therapeutics Market Share by Regions: 2020 VS 2026
Figure 12. Global Chronic Plaque Psoriasis Therapeutics Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Chronic Plaque Psoriasis Therapeutics Market Share by Players in 2019
Figure 15. Global Top Chronic Plaque Psoriasis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Chronic Plaque Psoriasis Therapeutics as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Chronic Plaque Psoriasis Therapeutics Revenue in 2019
Figure 17. North America Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed
尋常性乾癬治療の世界市場（～2026年） Plaque psoriasis is an inherited systemic inflammatory disease of immune dysfunction that causes plaques of elevated, scaling, inflamed skin that is often quite itchy. When treating plaque psoriasis, it must be remembered that topical medications and light will have difficulty penetrating through th…- 全身性乾癬治療薬の世界市場（～2026年） Psoriasis is an autoimmune skin disease that causes scaling, skin redness and irritation. Psoriasis causes red, scaly patches that are generally found on the elbows, fingernails, scalp, palms, knees, face, feet and inside the mouth. Factors that can trigger psoriasis include infections, heavy alcoho…
- 乾癬治療薬の世界市場（～2026年） Psoriasis is considered to be a persistent skin disorder that is characterized mainly by skin irritation and scaly rashes where the skin cells multiply up to 10 times faster than normal. Psoriasis majorly affects the knees, elbows, and scalp. The major objective of the therapy for this disease is to…
- 慢性リンパ性白血病（CLL）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Chronic Lymphocytic Leukemia Therapeutics Market The global Chronic Lymphocytic Leukemia Therapeutics market size is projected to reach US$ 9390.9 million by 2026, from US$ 8411.2 million in 2020, at a CAGR of 10.8%% during 2021-2026. Global Chronic Lymphocytic L…
- 慢性腰痛治療の世界市場（～2026年） Low back pain can be standardized into two categories, acute and chronic. Pain for less than three months can be classified as acute, while continued pain for more than three months is classified as chronic. Market Analysis and Insights: Global Chronic Low Back Pain Treatment Market The global Chron…